Inmunotek S.l.
Clinical trials sponsored by Inmunotek S.l., explained in plain language.
-
New allergy treatment shows promise for dust mite sufferers
Disease control CompletedThis study tested a type of allergy immunotherapy (Clustoid®) for people with dust mite allergies. It included 140 patients aged 5 to 65 who received the treatment for at least one year. The goal was to see if it reduces allergy symptoms and the need for medication, while also ch…
Sponsor: Inmunotek S.L. • Aim: Disease control
Last updated May 26, 2026 05:31 UTC
-
Under-the-Tongue vaccine shows promise for COPD patients
Disease control CompletedThis study tested a bacterial vaccine spray (MV130) taken daily under the tongue for 12 months in 198 adults with moderate to severe COPD. The goal was to see if it could reduce the number and severity of lung flare-ups compared to a placebo. Researchers also monitored safety and…
Phase: PHASE2, PHASE3 • Sponsor: Inmunotek S.L. • Aim: Disease control
Last updated May 19, 2026 11:47 UTC
-
Grass allergy test study aims to improve accuracy
Knowledge-focused CompletedThis study tested two grass allergen extracts (timothy and orchard grass) on the skin of 31 people with grass allergies. The goal was to find the right concentration that causes a skin reaction similar to histamine, a standard control. This helps standardize allergy skin tests fo…
Phase: NA • Sponsor: Inmunotek S.L. • Aim: Knowledge-focused
Last updated May 22, 2026 13:52 UTC